Editor's Note :

close editor's note Editor's Note :

We’re hosting a symposium on the Roberts court and the First Amendment’s religion clauses. In a series of six essays, scholars and commentators will analyze major decisions from the 2019-20 term and look to the future of the court’s religion jurisprudence. Click to follow along.

Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc.

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
19-1451 Fed. Cir. TBD TBD TBD TBD TBD

Issues: (1) Whether, in a pending case, a court can refuse to entertain a constitutional, separation-of-powers challenge based on an intervening change of law on the grounds of forfeiture; and (2) whether the U.S. Court of Appeals for the Federal Circuit’s obviousness holding is an unwarranted expansion of the Supreme Court’s decision in KSR International Co. v. Teleflex Inc. and is inconsistent with the Patent Act.

DateProceedings and Orders (key to color coding)
Jun 26 2020Petition for a writ of certiorari filed. (Response due August 3, 2020)
Jul 28 2020Motion to extend the time to file a response from August 3, 2020 to August 24, 2020, submitted to The Clerk.
Jul 29 2020Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.
 
Share:
Term Snapshot
At a Glance
Awards